ANNEX 2:
ADDITIONAL INFORMATION REGARDING THE PARTICIPANTS
Beneficial Ownership of Common Stock
The percentages set forth below are calculated based upon an aggregate of 80,468,304 shares of Common Stock (including unvested Common Stock) outstanding as of March 31, 2022 (which number is provided in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2021, filed with the SEC on May 2, 2022).
Ms. Drake beneficially owns 316,131 shares of Common Stock (representing less than 1% of the outstanding Common Stock), among which 56,870 shares of Common Stock are directly beneficially owned by Ms. Drake, 253,711 shares of Common Stock are held by EPD 2018 Trust dated August 7, 2018 and indirectly beneficially owned by Ms. Drake and 5,550 shares of Common Stock are held by Charitable Gift Fund and indirectly beneficially owned by Ms. Drake.
Ms. Drake owns Restricted Stock Units (“RSUs”) for 32,231 shares of Common Stock, of which RSUs for 5,303 shares of Common Stock vest on March 2, 2023, RSUs for 19,691 shares of Common Stock vest in three equal installments beginning on February 28, 2023 and 7,237 RSUs vest in one third increments on March 1st of each year, becoming fully vested in 2024. These awards were granted net of 9,382 shares relinquished to pay withholding taxes payable in connection with an election made pursuant to Section 83(b) of the Code. In addition, Ms. Drake owns Stock Appreciation Rights (“SARs”) for 171,405 shares of Common Stock, of which: (i) SARs for 13,189 shares of Common Stock are exercisable on April 5, 2019 and expiring on April 5, 2023, (ii) SARs for 53,028 shares of Common Stock are exercisable on May 1, 2020 and expiring on May 1, 2024; (iii) SARs for 46,768 shares of Common Stock are exercisable on February 27, 2021 and expiring on February 27, 2025 and (iv) SARs for 58,420 shares of Common Stock are exercisable on February 28, 2022 and expiring on February 28, 2026. Such SARs and RSUs were awarded to Ms. Drake in her capacity as a director and officer of the Company.
On behalf of General Chilton, 20,436 shares of Common Stock are held by a “rabbi trust,” the receipt of which has been deferred by General Chilton pursuant to the Company’s Deferred Compensation Plan for Nonemployee Directors. Such 20,436 shares of Common Stock are not deemed to be beneficially owned by General Chilton.
Mr. Corcoran beneficially owns 107,301 shares of Common Stock (representing less than 1% of the outstanding Common Stock), among which 3,699 shares of Common Stock are directly beneficially owned by Mr. Corcoran and 103,602 shares of Common Stock are held by Thomas A. Corcoran TTEE U/A DTD 07/16/2001 Trust and indirectly beneficially owned by Mr. Corcoran.
Ms. James beneficially owns 29 shares of Common Stock (representing less than 0.01% of the outstanding Common Stock), all of which are held by Deborah Lee James Living Trust.
On behalf of General Lord, 41,911 shares of Common Stock are held by a “rabbi trust,” the receipt of which has been deferred by General Lord pursuant to the Company’s Deferred Compensation Plan for Nonemployee Directors. Thus, such 41,911 shares of Common Stock are not deemed to be beneficially owned by General Lord.
None of Mmes. Baker and Blakey or General Bolden own beneficially or of record any securities of the Company, nor have they entered into any transactions in securities of the Company during the past two years.
Please see Annex I for a list of all transactions in the securities of the Company effectuated by the Participants within the past two years.
II-1